COMRESP Trademark

Trademark Overview


On Friday, June 14, 2024, a trademark application was filed for COMRESP with the United States Patent and Trademark Office. The USPTO has given the COMRESP trademark a serial number of 98601278. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, April 7, 2025. This trademark is owned by ModernaTx, Inc.. The COMRESP trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
comresp

General Information


Serial Number98601278
Word MarkCOMRESP
Filing DateFriday, June 14, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, April 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModernaTx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambriidge, MA 02142

Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambriidge, MA 02142

Trademark Events


Event DateEvent Description
Friday, June 14, 2024NEW APPLICATION ENTERED
Friday, June 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 24, 2024ASSIGNED TO PETITION STAFF
Monday, June 17, 2024TEAS PETITION TO DIRECTOR RECEIVED
Wednesday, July 3, 2024PETITION TO DIRECTOR GRANTED
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024ASSIGNED TO EXAMINER
Monday, July 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 15, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 7, 2025SOU TEAS EXTENSION RECEIVED
Monday, April 7, 2025SOU EXTENSION 1 FILED
Monday, April 7, 2025SOU EXTENSION 1 GRANTED
Monday, April 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords


comresp human vaccines